Presentation is loading. Please wait.

Presentation is loading. Please wait.

Revision of the venous clinical severity score: Venous outcomes consensus statement: Special communication of the American Venous Forum Ad Hoc Outcomes.

Published byLeslie Evans Modified over 5 years ago

Similar presentations

Presentation on theme: "Revision of the venous clinical severity score: Venous outcomes consensus statement: Special communication of the American Venous Forum Ad Hoc Outcomes."— Presentation transcript:

1 Revision of the venous clinical severity score: Venous outcomes consensus statement: Special communication of the American Venous Forum Ad Hoc Outcomes Working Group  Michael A. Vasquez, MD, Eberhard Rabe, Prof, Dr, Robert B. McLafferty, MD, Cynthia K. Shortell, MD, William A. Marston, MD, David Gillespie, MD, Mark H. Meissner, MD, Robert B. Rutherford, MD  Journal of Vascular Surgery  Volume 52, Issue 5, Pages (November 2010) DOI: /j.jvs Copyright © 2010 Society for Vascular Surgery Terms and Conditions

2 Fig 1 Corona phlebectatica.
Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

3 Fig 2 Skin pigmentation. A, Perimalleolar. B, Lower third calf. C, Above lower third calf. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

4 Fig 3 Inflammation. A, Cellulitis. B, Dermatitis. C, Venous eczema.
Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

5 Fig 4 Induration. A, White atrophy. B, Lipodermatosclerosis.
Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

6 Fig 5 Number of active ulcers (remains 1 ulcer in healing phase).
Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

7 Fig 6 The “visual language” of VCSS. Consistency in physician scoring and reporting allows a common language of venous disease to emerge. A, Before treatment basic clinical CEAP 3-VCSS 7. Revised VCSS scoring as follows: Pain = 1, VV = 2, Edema = 2, Pigmentation = 0, Inflammation = 0, Induration = 0, Active ulcers, size, duration = 0, Compression = 2. Total VCSS = 7. B, After treatment, scoring changes to clinical CEAP 2-VCSS 3. Pain = 0, VV = 1, Edema = 0, Pigmentation = 0, Inflammation = 0, Induration = 0, Active ulcers, size, duration = 0, Compression = 2. Total VCSS = 3.Clinical descriptorAbsent (0)Mild (1)Moderate (2)Severe (3)PainNoneOccasionalDaily not limitingDaily limitingVaricose veinsNoneFewCalf or thighCalf and thighVenous edemaNoneFoot and ankleBelow kneeKnee and aboveSkin pigmentationNoneLimited perimalleolarDiffuse lower 1/3 calfWider above lower 1/3 calfInflammationNoneLimited perimalleolarDiffuse lower 1/3 calfWider above lower 1/3 calfIndurationNoneLimited perimalleolarDiffuse lower 1/3 calfWider above lower 1/3 calfNo. active ulcersNone123 or moreUlcer durationNone<3 mo3-12 mo>1 yActive ulcer sizeNone<2 cm2-6 cm>6 cmCompression therapyNoneIntermittentMost daysFully comply Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

8 Fig 7 A, Before treatment clinical C4 -VCSS 16. Pain = 2, VV = 1, Edema = 2, Pigmentation = 3, Inflammation = 3, Induration = 3, Active ulcers, size, duration = 0, Compression = 2. Total VCSS = 16. B, Four months after treatment, patient remains clinical C4, but C4-V9. Pain = 0, VV = 1, Edema = 1, Pigmentation = 3, Inflammation = 0, Induration = 2, Active ulcers, size, duration = 0, Compression = 2. Total VCSS = 9. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

9 Fig 8 A, Prior to treatment, clinical C6-V18. Pain = 3, VV = 3, Edema = 2, Pigmentation = 3, Inflammation = 1, Induration = 2, Active ulcers = 1, size = 1, duration = 1, Compression = 1. Total VCSS = 18. B, One month after treatment, clinical C5-V11. Pain = 1, VV = 2, Edema = 1, Pigmentation = 3, Inflammation = 0, Induration = 2, Active ulcers = 0, size = 0, duration = 0, Compression = 2. Total VCSS = 11. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

10 Fig 9 The broadened language of uniting CEAP with VCSS in CVD. More information is relayed in stating C6-V25 changes to C6-V21 and at last C5-V7. A, Pre – Pain = 3, VV = 3, Edema = 2, Pigmentation = 2, Inflammation = 3, Induration = 2, Active ulcers = 1, size = 3, duration = 3, Compression = 3. Total VCSS = 25. B, 1 week post – Pain = 2, VV = 2, Edema = 1, Pigmentation = 2, Inflammation = 2, Induration = 2, Active ulcers = 1, size = 3, duration = 3, Compression = 3. Total VCSS = 21. C, 2 months post – Pain = 0, VV = 1, Edema = 0, Pigmentation = 2, Inflammation = 0, Induration = 2, Active ulcers = 0, size = 0, duration = 0, Compression = 2. Total VCSS = 7. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

Download ppt "Revision of the venous clinical severity score: Venous outcomes consensus statement: Special communication of the American Venous Forum Ad Hoc Outcomes."

Similar presentations

In search of optimal compression therapy for venous leg ulcers: A meta-analysis of studies comparing divers bandages with specifically designed stockings 

In search of optimal compression therapy for venous leg ulcers: A meta-analysis of studies comparing divers bandages with specifically designed stockings 
Intermittent pneumatic compression of the foot and calf improves the outcome of catheter-directed thrombolysis using low-dose urokinase in patients with.

Intermittent pneumatic compression of the foot and calf improves the outcome of catheter-directed thrombolysis using low-dose urokinase in patients with.
Clinical evaluation of recombinant human platelet – derived growth factor for the treatment of lower extremity diabetic ulcers  David L. Steed, MD, the.

Clinical evaluation of recombinant human platelet – derived growth factor for the treatment of lower extremity diabetic ulcers  David L. Steed, MD, the.
Distribution and prevalence of reflux in the superficial and deep venous system in the general population – results from the Bonn Vein Study, Germany 

Distribution and prevalence of reflux in the superficial and deep venous system in the general population – results from the Bonn Vein Study, Germany 
Evaluation of the Superficial Venous System and When to Treat

Evaluation of the Superficial Venous System and When to Treat
Alfred Obermayer, MD, Katharina Garzon, MSc 

Alfred Obermayer, MD, Katharina Garzon, MSc 
Without prejudice Journal of Vascular Surgery

Without prejudice Journal of Vascular Surgery
Postoperative pain and early quality of life after radiofrequency ablation and mechanochemical endovenous ablation of incompetent great saphenous veins 

Postoperative pain and early quality of life after radiofrequency ablation and mechanochemical endovenous ablation of incompetent great saphenous veins 
Susanna L. Matsen, MD, Bruce A. Perler, MD, MBA, David C

Susanna L. Matsen, MD, Bruce A. Perler, MD, MBA, David C
Management of venous leg ulcers: Clinical practice guidelines of the Society for Vascular Surgery® and the American Venous Forum  Thomas F. O’Donnell,

Management of venous leg ulcers: Clinical practice guidelines of the Society for Vascular Surgery® and the American Venous Forum  Thomas F. O’Donnell,
Postoperative pain and early quality of life after radiofrequency ablation and mechanochemical endovenous ablation of incompetent great saphenous veins 

Postoperative pain and early quality of life after radiofrequency ablation and mechanochemical endovenous ablation of incompetent great saphenous veins 
Distribution and prevalence of reflux in the superficial and deep venous system in the general population – results from the Bonn Vein Study, Germany 

Distribution and prevalence of reflux in the superficial and deep venous system in the general population – results from the Bonn Vein Study, Germany 
Iliac-caval stenting in the obese

Iliac-caval stenting in the obese
The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and.

The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and.
Incidence of and risk factors for iliocaval venous obstruction in patients with active or healed venous leg ulcers  William Marston, MD, Daniel Fish,

Incidence of and risk factors for iliocaval venous obstruction in patients with active or healed venous leg ulcers  William Marston, MD, Daniel Fish,
The utility of the venous clinical severity score in 682 limbs treated by radiofrequency saphenous vein ablation  Michael A. Vasquez, MD, Jiping Wang,

The utility of the venous clinical severity score in 682 limbs treated by radiofrequency saphenous vein ablation  Michael A. Vasquez, MD, Jiping Wang,
Postthrombotic or non-postthrombotic severe venous insufficiency: Impact of removal of superficial venous reflux with or without subcutaneous fasciotomy 

Postthrombotic or non-postthrombotic severe venous insufficiency: Impact of removal of superficial venous reflux with or without subcutaneous fasciotomy 
Peter Henke, MD, Bob Kistner, MD, Thomas W

Peter Henke, MD, Bob Kistner, MD, Thomas W
Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia  Louis L. Nguyen,

Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia  Louis L. Nguyen,
Robert B. McLafferty, MD, Joanne M. Lohr, MD, Joseph A

Robert B. McLafferty, MD, Joanne M. Lohr, MD, Joseph A

Similar presentations

Ads by Google